Abstract:Key PointsSince the discovery of induced pluripotent stem cell (iPSC) reprograming, many protocols to generate human neural cells, including specific neuronal subtypes, astrocytes and other glial cells have emerged.Guided differentiation protocols for the production of specific brain cell subtypes from human pluripotent stem cells (hPSCs) follow known developmental pathways. The precise combination of molecular cues allows scientists to guide neural commitment, early regionalization and cell type specification to develop cultures enriched for specific neuronal subtypes.The generation of functional neurons and glia from hPSCs can be markedly improved by controlling the cellular environment in vitro, and advances in developing optimized culture scaffolds, culture media and 3D neural organoid cultures enhance our ability to provide more sophisticated tissue models of the brain. Authentic models of physiological human neuronal tissue in vitro will provide novel means to study human neuronal development and disease.Functional neural cell cultures can also be obtained by converting primary human somatic cells, such as skin fibroblasts, directly into neurons or glia. Direct conversion into induced neurons (iNs) is typically achieved through the overexpression of pro-neuronal transcription factors; alternative methods based on RNA interference or small molecules are also being developed.Direct conversion of human somatic cells into defined neuronal subtypes can be achieved through combined overexpression of general pro-neuronal drivers and secondary lineage-specifying transcription factors.The increasing number of available methods to generate different neural cell types from human skin cells demands a careful consideration of practical as well as conceptual differences between hPSC differentiation and direct conversion methods. Practical concerns may include duration, difficulty, costs, efficiency, available cell numbers and subtypes that can be generated by a certain method; conceptual differences encompass the influence of the respective reprogramming method on the genomic identity of the derived cell culture (for example, clonal or mosaic), their epigenetic state (for example, rejuvenation), as well as whether a certain method recapitulates relevant neurodevelopmental and maturation.

Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Human Induced Pluripotent Stem Cell-Derived Pericytes As Scalable and Editable Source to Study Direct Lineage Reprogramming into Induced Neurons.

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Differentiation of human induced pluripotent stem cells into cortical neural stem cells

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Direct Conversion of Somatic Cells into Induced Neurons

Neural Differentiation of Human Induced Pluripotent Stem Cells Follows Developmental Principles but with Variable Potency

A comprehensive protocol for efficient differentiation of human NPCs into electrically competent neurons

Building on a Solid Foundation: Adding Relevance and Reproducibility to Neurological Modeling Using Human Pluripotent Stem Cells

Direct Cell Reprogramming and Phenotypic Conversion: An Analysis of Experimental Attempts to Transform Astrocytes into Neurons in Adult Animals

Advances in Human Stem Cell-Derived Neuronal Cell Culturing and Analysis

High-throughput identification of factors promoting neuronal differentiation of human neural progenitor cells in microscale 3D cell culture

Large-Scale Production of Mature Neurons from Human Pluripotent Stem Cells in a Three-Dimensional Suspension Culture System

Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases

NGN2-based neuronal programming of hiPSCs in an automated microfluidic platform

A Hybrid 2D-to-3D in vitro Differentiation Platform Improves Outcomes of Cerebral Cortical Organoid Generation in hiPSCs

Exploring the Functional Heterogeneity of Directly Reprogrammed Neural Stem Cell-Derived Neurons via Single-Cell RNA Sequencing

Conversion of Human Fibroblasts into Induced Neural Stem Cells by Small Molecules